← FDA Drug Approvals (Drugs@FDA)

PACLITAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2024-10-08

Drug application

FDA Application #

ANDA212700

Application type

Abbreviated New Drug Application (Generic)

Brand name

PACLITAXEL

Generic name

PACLITAXEL

Active ingredients

PACLITAXEL

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HENGRUI PHARMA

Manufacturer

Sandoz Inc

First approval

2024-10-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown